Distribution of neutralizing measles antibodies serum concentration according to age in women of childbearing age in France in 2005-2006;Distribution en fonction de l'âge de la concentration sérique des anticorps neutralisants antirougeole chez les femmes en âge de procréer en France en 2005-2006

Archives de Pediatrie

Volumn 15, Issue 10, 2008, Pages 1525-1530

  Gagneur, A ^a,i   Pinquier, D ^b   Aubert, M ^c   Soubeyrand, B ^c   Balu, L ^d   Brissaud, O ^e   Gras Le Guen, C ^f   Hau Rainsard, I ^g   Mory, O ^h   Picherot, G ^f   De Pontual, L ^d   Stephan, J L ^h   Reinert, P ^g  

^a BREST UNIVERSITY HOSPITAL   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c SANOFI PASTEUR   (France)

^d HÔPITAL JEAN VERDIER   (France)

^e HÔPITAL PELLEGRIN   (France)

^f Centre d'Investigation Clinique en Biothérapie   (France)

^g Service de Pneumologie Pathologies Environnementales   (France)

^h HÔPITAL NORD   (France)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASSAY; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FRANCE; GEOMETRY; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; MEASLES; OUTPATIENT; POPULATION; PREGNANCY; PROGENY;

EID: 53449099660     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.07.011     Document Type: Article

References (22)

1. Bonmarin I., Parent du Chatelet I., and Levy-Bruhl D. Rougeole en France : impact épidémiologique d'une couverture vaccinale sub-optimale. Bull Epidemiol Hebd 16 (2004) 61-64
2. Calendrier vaccinal 2005 et autres avis du Conseil supérieur d'hygiène publique de France, Bull Epidemiol Hebd 2005;29-30:142.
3. Avis du Haut conseil de la santé publique. Calendrier vaccinal 2007. Bull Epidemiol Hebd 2007;31-2:272-3.
4. Spika J.S., Wassilak S., Pebody R., et al. Measles and rubella in the World Health Organization European region: diversity creates challenges. J Infect Dis 187 (2003) S191-S197
5. Wichmann O., Hellenbrand W., Sagebiel D., et al U. Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J 26 (2007) 782-786
6. Six C., Franke F., Mantey K., et al. Measles outbreak in the Provence-Alpes-Côte-d'Azur region, France, January-July 2003. Euro Surveillance 10 (2005) 46-48
7. Ohsaki M., Tsutsumi H., Takeuchi R., et al. Reduced passive measles immunity in infants of mothers who have not been exposed to measles outbreaks. Scand J Infect Dis 31 (1999) 17-19
8. Siegrist C.A., Córdova M., Brandt C., et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 16 (1998) 1409-1414
9. Altintaş D.U., Evliyaoǧlu N., Kilinç B., et al. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. Eur J Epidemiol 12 (1996) 647-648
10. Nicoara C., Zäch K., Trachsel D., et al. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses. Clin Diagn Lab Immunol 6 (1999) 868-871
11. Janaszek W., and Slusarczyk J. Immunity against measles in populations of women and infants in Poland. Vaccine 21 (2003) 2948-2953
12. Maldonado Y.A., Lawrence E.C., DeHovitz R., et al. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96 (1995) 447-450
13. Gonçalves G., Cutts F.T., Hills M., et al. Transplacental transfer of measles and total IgG. Epidemiol Infect 122 (1999) 273-279
14. Nates S.V., Cumino A., Isa M.B., et al. Measles antibody in pregnant Argentinian women relative to vaccine-induced immunity and natural infection. Pediatr Infect Dis J 18 (1999) 937-939
15. Markowitz L.E., Albrecht P., Rhodes P., et al., Kaiser Permanente Measles Vaccine Trial Team. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Pediatrics 97 (1996) 53-58
16. Brugha R., Ramsay M., Forsey T., et al. A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect 117 (1996) 519-524
17. Carson M.M., Spady D.W., Albrecht P., et al. Measles vaccination of infants in a well-vaccinated population. Pediatr Infect Dis J 14 (1995) 17-22
18. Chen R.T., Markowitz L.E., Albrecht P., et al. Measles antibodies: reevaluation of protective titers. J Infect Dis 162 (1990) 1036-1042
19. Antona D, Bussière E, Guignon N, et al. La couverture vaccinale en France en 2001. Bull Epidemiol Hebd 2003;36:169-72.
20. Papania M., Baughman A.L., Lee S., et al. Increased susceptibility to measles in infants in the United States. Pediatrics 104 (1999) e59
21. Leudiran E., and Van Damme P. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine 25 (2007) 6296-6304
22. Office fédéral de la santé publique et Commission fédérale pour les vaccinations. Swiss vaccination plan 2006 - status. Disponible sur http://www.swiss-paediatrics.org/guidelines/impfplan_06-fr.pdf. Consulté le 18 novembre 2006.